These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27065076)

  • 41. The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells.
    Lin AE; Mak TW
    Curr Opin Immunol; 2007 Dec; 19(6):665-73. PubMed ID: 18036806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
    Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D
    Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune Regulation.
    Klein M; Bopp T
    Front Immunol; 2016; 7():315. PubMed ID: 27621729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units.
    Wehbi VL; Taskén K
    Front Immunol; 2016; 7():222. PubMed ID: 27375620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. cAMP: a multifaceted modulator of immune synapse assembly and T cell activation.
    Arumugham VB; Baldari CT
    J Leukoc Biol; 2017 Jun; 101(6):1301-1316. PubMed ID: 28356349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases.
    Li H; Zuo J; Tang W
    Front Pharmacol; 2018; 9():1048. PubMed ID: 30386231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression.
    Sasi B; Ethiraj P; Myers J; Lin AP; Jiang S; Qiu Z; Holder KN; Aguiar RCT
    Leukemia; 2021 Jul; 35(7):1990-2001. PubMed ID: 33299141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022.
    Crocetti L; Floresta G; Cilibrizzi A; Giovannoni MP
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From metabolomics to therapeutics: identifying causal metabolites and potential drugs for the treatment of osteoarthritis.
    Li H; Sun J; Zhang J; Chen Y; Zhao Y; Cao R; Kong N; Duan X; Guan H; Tian R; Wang K; Yang P
    Inflammopharmacology; 2024 Nov; ():. PubMed ID: 39488818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The function of serine/threonine-specific protein kinases in B cells.
    Han Z; Benlagha K; Lee P; Park CS; Filatov A; Byazrova MG; Miller H; Yang L; Liu C
    Front Immunol; 2024; 15():1459527. PubMed ID: 39445011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 Pathway.
    Liu Y; Liu Z; Li X; Li W; Yang Z; Jiao R; Wang Q; Meng L; Zhang T; Liu J; Chai D; Zhang N; Peng S; Zhou H; Yang C
    Inflammation; 2024 Oct; ():. PubMed ID: 39438343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decoding the mosaic of inflammatory bowel disease: Illuminating insights with single-cell RNA technology.
    Liu L; Davidorf B; Dong P; Peng A; Song Q; He Z
    Comput Struct Biotechnol J; 2024 Dec; 23():2911-2923. PubMed ID: 39421242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What every clinician should know about inflammation in COPD.
    Wechsler ME; Wells JM
    ERJ Open Res; 2024 Sep; 10(5):. PubMed ID: 39319045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclic Adenosine Monophosphate Signaling in Chronic Kidney Disease: Molecular Targets and Therapeutic Potentials.
    Delrue C; Speeckaert R; Moresco RN; Speeckaert MM
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions.
    Wilkins JM; Mangalaparthi KK; Netzel BC; Sherman WA; Guo Y; Kalinowska-Lyszczarz A; Pandey A; Lucchinetti CF
    Front Mol Neurosci; 2024; 17():1448215. PubMed ID: 39234409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction and validation of a TTN mutation associated immune prognostic model for evaluating immune microenvironment and outcomes of gastric cancer: An observational study.
    Chen R; Yao Z; Jiang L
    Medicine (Baltimore); 2024 Jul; 103(29):e38979. PubMed ID: 39029079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The physical and cellular mechanism of structural color change in zebrafish.
    Gur D; Moore AS; Deis R; Song P; Wu X; Pinkas I; Deo C; Iyer N; Hess HF; Hammer JA; Lippincott-Schwartz J
    Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2308531121. PubMed ID: 38805288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunomodulatory Effects of Fluoroquinolones in Community-Acquired Pneumonia-Associated Acute Respiratory Distress Syndrome.
    Yudhawati R; Wicaksono NF
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    Caratis F; Opiełka M; Hausmann M; Velasco-Estevez M; Rojek B; de Vallière C; Seuwen K; Rogler G; Karaszewski B; Rutkowska A
    PLoS One; 2024; 19(3):e0283060. PubMed ID: 38527054
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.